Somatostatin receptor scintigraphy and octreotide treatment in patients with thyroid eye disease

Clinical Endocrinology

Volumn 42, Issue 6, 1995, Pages 571-580

  Krassas, G E ^a   Dumas, A ^a   Pontikides, N ^a   Kaltsas, T ^a  

^a NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RETROBULBAR OPTIC NEUROPATHY; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBCUTANEOUS DRUG ADMINISTRATION; THYROTOXICOSIS;

EID: 0029012202     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.1995.tb02682.x     Document Type: Article

References (21)

1. Chang, T.C., Kao, S.C.S. & Huang, K.M. (1992a) Octreotide and Graves' ophthalmopathy and pretibial myxoedema. British Medical Journal, 304, 158.
2. Chang, T.C., Yao, W.C. & Chang, C.C. (1992b) Octreotide and urinary glycosaminoglycan in Graves' disease. British Medical Journal, 304, 1444.
3. Donaldson, S.S., Bagshaw, M.A. & Kriss, J.P. (1973) Supervoltage orbital radiotherapy for Graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism, 37, 276–285.
4. Hansson, H.A., Petruson, B. & Skottnerm, A. (1986) Somatomedin C in pathogenesis of malignant exophthalmos of endocrine origin. Lancet, i, 218–219.
5. Ichise, M., Toyam, H., Vines, D.C., Chung, D.G. & Kirsch, J.C. (1992) Neuroanatomical localization for clinical SPECT perfusion brain imaging: a practical proportional grid method. Nuclear Medicine Communications, 13, 861–866.
6. Krassas, G.E., Dumas, A., Bougoulia, M., Pontikides, N. & Kaltsas, Th. (1993) Somatostatin receptor scintigraphy in patients with endocrine ophthalmopathy. First experience. Journal of Endocrinological Investigation, 16 (Suppl. 1–8), 150.
7. Lamberts, S.W.J., Bakker, W.H., Reubi, J.C. & Krenning, E.P. (1990a) Somatostatin‐receptor imaging in the localization of endocrine tumours. New England Journal of Medicine, 323, 1246–1249.
8. Lamberts, S.W.J., Holland, L.J., Koetsveld, P.M., Reubi, J.C., Bruining, H.A., Bakker, W.H. & Krenning, E.P. (1990b) Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumours. Consequences with regard to diagnosis, localization and therapy. Journal of Clinical Endocrinology and Metabolism, 71, 566–574.
9. Lamberts, S.W.J., Krenning, E.P. & Reubi, J.C. (1991) The role of somatostatin and its analogues in the diagnosis and treatment of tumours. Endocrine Reviews, 12, 450–482.
10. Malec, P., Zeman, K., Markiewicz, K., Tchorzewski, H., Nowak, Z. & Baj, Z. (1989) Short term somatostatin infusion affects T‐lymphocyte responsiveness in humans. Immunopharmacology, 17, 45–49.
11. O'Brien, J.F. (1984) Glycosaminoglycan and exophthalmos. In The Eye and Orbit in Thyroid Disease (eds C. A. Gorman, R. R. Waller & J. A. Dyer), pp 43–47. Raven, New York.
12. O'Dorisio, T.M. (1991) Somatostatin analogues: their rationale and clinical interest. In Clinical relevance of Octreoscan‐111 the somatostatin‐analogue labelled with Indium‐Ill. EANM meeting, September 3, Abstract book, p. 4.
13. Oei, H.Y., Krenning, E.P. & Lamberts, S.W.J. (1991) In: Somatostatin receptor imaging using Octreoscan‐III. pp. 5–6. Mallinkrodt Medical B.V., The Netherlands.
14. Perros, P., Weightman, D.R., Crombie, A.L. & Kendall‐Taylor, P. (1990) Azathioprine in the treatment of thyroid‐associated ophthalmopathy. Acta Endocrinologica, 122, 8–12.
15. Postema, P.T.E., Krenning, E.P., Oei, H.Y., Kooij, P.P.M., Wijngaarde, R., Lamberts, S.W.J., Wiersinga, W.H., Prummel, M.F., Van Royen, E.A., Poublon, R.M.L. & Hennemann, G. (1992) Thyroidal and orbital radiolabeled somatostatin analog scintigraphy in Graves' disease and ophthalmic Graves' disease. Thyroid, 2 (Suppl. 1), S‐31.
16. Reubi, J.C. & Landolt, A.M. (1984) High density of somatostatin receptors in pituitary tumours from acromegalic patients. Journal of Clinical Endocrinology and Metabolism, 59, 1148–1153.
17. Reubi, J.C., Maurer, R., Klijn, J.G.M., Stefanko, S.Z., Foekens, J.A., Blaauw, G., Blankenstein, M.A. & Lamberts, S.W.J. (1986) High incidence of somatostatin receptors in human meningiomas: biochemical characterization. Journal of Clinical Endocrinology and Metabolism, 63, 433–438.
18. Reubi, J.C., Maurer, R., Von Werber, K., Torhorst, J., Klijn, J.G.M. & Lamberts, S.W.J. (1987a) Somatostatin receptors in human endocrine tumors. Cancer Research, 47, 551–558.
19. Reubi, J.C., Lang, W., Maurer, R., Koper, J.W. & Lamberts, S.W.J. (1987b) Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system. Cancer Research, 47, 5758–5765.
20. Reubi, J.C., Waser, B., van Hagen, M., Lamberts, S.W.J., Krenning, E.P., Gebbers, J.O. & Laissue, J.A. (1992) In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas. International Journal of Cancer, 50, 895–900.
21. Werner, S.C. (1977) Modification of the classification of the eye changes of Graves' disease: recommendations of the ad hoc committee of the American Thyroid Association. Journal of Clinical Endocrinology and Metabolism, 44, 203–204.